| abstract |
The present invention discloses a method for investigating individual-level systemic metabolic abnormalities using whole-body SUV images. , through which sampling areas were selected; the subjects included healthy controls, lung cancer groups, subjects 30 days after Covid‑19 discharge, and subjects with unexplained gastrointestinal bleeding; construct The individual connection network of different subjects, and the degree of metabolic abnormality in each sampling area of different subjects is obtained through the individual connection network of different subjects; the control group is determined by the degree of metabolic abnormality in each sampling area of different subjects Homogeneity analysis, lung cancer group heterogeneity analysis, group- and individual-level network analysis, and individual network and single-organ analysis. The methods of the present invention can potentially identify systemic metabolic abnormalities. |